drugset / Trial / NCT05412979

A Study Evaluating the Safety and Efficacy of Hormone Replacement Therapy With ST-1891 Compared to Levothyroxine in Patients With Primary Hypothyroidism

NCT05412979

Phase 2 Completed 490 enrolled Sention Therapeutics, LLC
RandomizedParallel-groupQuadruple-blindTreatment

Summary

ST-1891-201 is a multicenter, randomized, double-blind, partial crossover, Phase 2 study evaluating the safety and efficacy of hormone replacement therapy with ST-1891 compared to levothyroxine in patients with primary hypothyroidism.

Timeline

Start
2022-04-29
Primary completion
2023-10-04
Completion
2023-10-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levothyroxine Other / unclassified
Subject ST-1891 Unknown

Indications